斷血炎膠囊(TRANSAMIN CAPSULES) |
內衛藥製字第015392號 |
TRANEXAMIC ACID |
2017-07-14 |
"貝靈"凝血纖維蛋白原注射液(HAEMOCOMPLETTAN P) |
衛署菌疫輸字第000439號 |
FIBRINOGEN HUMAN |
2017-11-24 |
"台灣第一三共" 斷血炎注射液(TRANSAMIN INJECTION "DAIICHI SANKYO") |
衛署藥製字第045154號 |
TRANEXAMIC ACID |
2017-04-24 |
"台灣第一三共" 斷血炎錠500毫克 (妥內散敏)(TRANSAMIN TABLETS 500MG) |
衛署藥製字第030331號 |
TRANEXAMIC ACID |
2015-04-17 |
諾和第七因子室溫注射劑(NovoSeven RT) |
衛署菌疫輸字第000878號 |
EPTACOG ALFA |
2015-12-07 |
諾和第七因子室溫注射劑(NovoSeven RT) |
衛署菌疫輸字第000878號 |
EPTACOG ALFA |
2015-12-07 |
血凝素第八因子注射劑(人類)250IU(KOATE-DVI ANTIHEMOPHILIC FACTOR (HUMAN) 250IU) |
衛署菌疫輸字第000320號 |
FACTOR VIII |
2016-12-12 |
血凝素第八因子注射劑(人類)500IU、1000IU(KOATE-DVI ANTIHEMOPHILIC FACTOR (HUMAN) 500IU,1000IU) |
衛署菌疫輸字第000319號 |
FACTOR VIII |
2016-12-12 |
血凝素第八因子注射劑(人類)500IU、1000IU(KOATE-DVI ANTIHEMOPHILIC FACTOR (HUMAN) 500IU,1000IU) |
衛署菌疫輸字第000319號 |
FACTOR VIII |
2016-12-12 |
新派瑞恩12%糖注射液(NEOPAREN No.1 Injection) |
衛署藥輸字第025708號 |
POTASSIUM ACETATE, SODIUM CITRATE HYDROUS, Calcium chloride hydrate, SODIUM CHLORIDE, GLUCOSE, L-ALANINE, L-ARGININE, L-ASPARTIC ACID, L- GLUTAMIC ACID, L-HISTIDINE, L-ISOLEUCINE, L-LEUCINE, L-LYSINE ACETATE, L-METHIONINE, L-PHENYLALANINE, L-PROLINE, L-SERINE, L-THREONINE, L-TRYPTOPHAN, L-TYROSINE, L-VALINE, GLYCINE (EQ TO AMINOACETIC ACID)(EQ TO GLYCOCOLL), ACETYLCYSTEINE, Magnesium sulfate hydrate, POTASSIUM PHOSPHATE ( eq to POTASSIUM PHOSPHATE DIBASIC), PANTHENOL, VITAMIN A OIL, BIOTIN, NICOTINAMIDE, Thiamine chloride hydrochloride, RIBOFLAVIN PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN (VIT B12), FOLIC ACID, ASCORBIC ACID, CHOLECALCIFEROL ( EQ TO VIT D3) ( EQ TO VITAMIN D3), TOCOPHEROL ACETATE, Zinc sulfate hydrate, Phytonadione |
2017-02-06 |
妥內散酸(Tranexamic Acid) |
衛署藥陸輸字第000352號 |
|
2016-04-11 |
妥內散酸(TRANEXAMIC ACID) |
衛署藥陸輸字第000095號 |
TRANEXAMIC ACID |
2016-04-11 |
伊美耐高純度第九凝血因子注射劑 600 國際單位(IMMUNINE PURIFIED FACTOR IX CONCENTRATE, VIRUS-INACTIVATED 600 IU) |
衛署菌疫輸字第000774號 |
HUMAN COAGULATION FACTOR IX |
2017-10-06 |
威保 50U/ml 抗抑制子凝血複合物(FEIBA 50U/ml) |
衛署菌疫輸字第000746號 |
HUMAN PLASMA PROTEIN WITH FACTOR VIII INHIBITOR BY PASSING ACTIVITY |
2017-10-16 |
威保 25U/ml 抗抑制子凝血複合物(FEIBA 25U/ml) |
衛署菌疫輸字第000747號 |
HUMAN PLASMA PROTEIN WITH FACTOR VIII INHIBITOR BY PASSING ACTIVITY |
2017-10-16 |
賓凝適第九凝血因子凍晶注射劑(BENEFIX{RFIX} COAGULATION FACTOR IX (RECOMBINANT)) |
衛署菌疫輸字第000608號 |
rFIX(Nonacog alfa) |
2016-12-15 |
賓凝適第九凝血因子凍晶注射劑(BENEFIX{RFIX} COAGULATION FACTOR IX (RECOMBINANT)) |
衛署菌疫輸字第000608號 |
rFIX(Nonacog alfa) |
2016-12-15 |
"貝靈"第八凝血因子500國際單位注射劑(HAEMATE P 500I.U.) |
衛署菌疫輸字第000427號 |
vWF: RCO activity, FACTOR VIII |
2017-04-05 |
"貝靈" 第八凝血因子注射劑(HAEMATE P) |
衛署菌疫輸字第000430號 |
FACTOR VIII |
2017-04-05 |
"貝靈" 第八凝血因子注射劑(HAEMATE P) |
衛署菌疫輸字第000430號 |
FACTOR VIII |
2017-04-05 |